Hématologie
Volume 29, supplement 1, Mars 2023
With the institutional support of
Volume 29, supplement 1, Mars 2023
Édito
Why a special issue on chronic B lymphoproliferations?
(p.3-4)
Véronique Leblond
Revues
B-cell receptor signalling in B-cell lymphoproliferative disorders
(p.5-13)
Grégory Lazarian, Florence Cymbalista
Evolution of therapeutic strategies at the pace of molecular understanding in Waldenström Macroglobulinemia
(p.14-22)
Damien Roos-Weil, Daphné Krzisch
Chronic lymphocytic leukaemia: a decade of targeted therapies
(p.23-7)
Romain Guièze
Therapeutic advances in marginal zone lymphoma over the last 10 years
(p.28-36)
Côme Bommier, Catherine Thieblemont
Ten years of improvement on mantle cell lymphoma treatment: from targeted therapies to cellular engineering
(p.36-43)
Valentin Letailleur, Benoît Tessoulin
Cardiovascular toxicities of BTK inhibitors
(p.44-50)
Joe-Elie Salem
Health democracy in action: Roles and professional tasks of patients as partners in care in oncology services
(p.51-6)
Catherine Tourette-Turgis, Marie-Pierre Dann